241 related articles for article (PubMed ID: 11340524)
21. [Epidemiological search for vancomycin-resistant enterococci in mainland of the Ryukyus].
Kisanuki K; Higa M; Nakasone I; Shiohira CM; Yamane N
Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi; 2008; 19(1-2):1-6. PubMed ID: 19583456
[TBL] [Abstract][Full Text] [Related]
22. A febrile neutropenic patient with Enterococcus gallinarum sepsis treated with daptomycin and gentamicin.
Barber GR; Lauretta J; Saez R
Pharmacotherapy; 2007 Jun; 27(6):927-32. PubMed ID: 17542774
[TBL] [Abstract][Full Text] [Related]
23. Polymicrobial bloodstream infection in pediatric patients: risk factors, microbiology, and antimicrobial management.
Sutter D; Stagliano D; Braun L; Williams F; Arnold J; Ottolini M; Epstein J
Pediatr Infect Dis J; 2008 May; 27(5):400-5. PubMed ID: 18398386
[TBL] [Abstract][Full Text] [Related]
24. Endocarditis due to vancomycin-resistant Enterococcus raffinosus successfully treated with linezolid: case report and review of literature.
Jasovich A; Ganaha MC; Ebi C; García RD; Blanco MA; Lopardo H
Rev Argent Microbiol; 2008; 40(4):204-7. PubMed ID: 19213241
[TBL] [Abstract][Full Text] [Related]
25. Invasive infections due to vancomycin-resistant enterococci in adult patients.
Jean SS; Fang CT; Wang HK; Hsue PR; Chang SC; Luh KT
J Microbiol Immunol Infect; 2001 Dec; 34(4):281-6. PubMed ID: 11825009
[TBL] [Abstract][Full Text] [Related]
26. Enterococcal meningitis: a clinical study of 39 cases and review of the literature.
Pintado V; Cabellos C; Moreno S; Meseguer MA; Ayats J; Viladrich PF
Medicine (Baltimore); 2003 Sep; 82(5):346-64. PubMed ID: 14530784
[TBL] [Abstract][Full Text] [Related]
27. [Vancomycin and high-level aminoglycoside resistant Enterococcus carriage and the risk factors related to resistance in hospitalized patients].
Yildirim M; Sencan I; Ozdemir D; Oksüz S; Yilmaz Z; Sahin I
Mikrobiyol Bul; 2007 Apr; 41(2):271-7. PubMed ID: 17682714
[TBL] [Abstract][Full Text] [Related]
28. Bacteremia caused by non-faecalis and non-faecium enterococcus species at a Medical center in Taiwan, 2000 to 2008.
Tan CK; Lai CC; Wang JY; Lin SH; Liao CH; Huang YT; Wang CY; Lin HI; Hsueh PR
J Infect; 2010 Jul; 61(1):34-43. PubMed ID: 20433865
[TBL] [Abstract][Full Text] [Related]
29. Bacteremia caused by Pantoea agglomerans and Enterococcus faecalis in a patient with colon cancer.
Christakis GB; Perlorentzou SP; Aslanidou M; Savva L; Zarkadis IK
J BUON; 2007; 12(2):287-90. PubMed ID: 17600887
[TBL] [Abstract][Full Text] [Related]
30. First recurrent infection with vancomycin-resistant enterococcus from Turkey.
Citak EC; Oguz A; Karadeniz C; Okur V; Basustaoglu A; Arman D
J Infect; 2006 Sep; 53(3):e147-50. PubMed ID: 16413059
[TBL] [Abstract][Full Text] [Related]
31. Risk factors and outcomes associated with non-Enterococcus faecalis, non-Enterococcus faecium enterococcal bacteremia.
de Perio MA; Yarnold PR; Warren J; Noskin GA
Infect Control Hosp Epidemiol; 2006 Jan; 27(1):28-33. PubMed ID: 16418983
[TBL] [Abstract][Full Text] [Related]
32. Clinical management of non-faecium non-faecalis vancomycin-resistant enterococci infection. Focus on Enterococcus gallinarum and Enterococcus casseliflavus/flavescens.
Monticelli J; Knezevich A; Luzzati R; Di Bella S
J Infect Chemother; 2018 Apr; 24(4):237-246. PubMed ID: 29396199
[TBL] [Abstract][Full Text] [Related]
33. Clinical profile and strain relatedness of recurrent enterococcal bacteremia.
Cheng AC; Murdoch DR; Harrell LJ; Barth Reller L
Scand J Infect Dis; 2005; 37(9):642-6. PubMed ID: 16126563
[TBL] [Abstract][Full Text] [Related]
34. Effectiveness of the antibiotic lock therapy for the treatment of port-related enterococci, Gram-negative, or Gram-positive bacilli bloodstream infections.
Del Pozo JL; Alonso M; Serrera A; Hernaez S; Aguinaga A; Leiva J
Diagn Microbiol Infect Dis; 2009 Feb; 63(2):208-12. PubMed ID: 19026506
[TBL] [Abstract][Full Text] [Related]
35. Isolation, distribution and prevalence of various species of enterococci isolated from clinical specimens in a tertiary care hospital.
Anbumani N; Menon T; Kalyani J; Mallika M
Indian J Pathol Microbiol; 2005 Oct; 48(4):534-7. PubMed ID: 16366120
[TBL] [Abstract][Full Text] [Related]
36. Clinical experience with daptomycin: bacteraemia and endocarditis.
Levine DP
J Antimicrob Chemother; 2008 Nov; 62 Suppl 3():iii35-39. PubMed ID: 18829724
[TBL] [Abstract][Full Text] [Related]
37. Vancomycin-resistant enterococcal bacteraemia: is daptomycin as effective as linezolid?
Mave V; Garcia-Diaz J; Islam T; Hasbun R
J Antimicrob Chemother; 2009 Jul; 64(1):175-80. PubMed ID: 19423543
[TBL] [Abstract][Full Text] [Related]
38. Impact of vancomycin resistance on mortality among patients with neutropenia and enterococcal bloodstream infection.
DiazGranados CA; Jernigan JA
J Infect Dis; 2005 Feb; 191(4):588-95. PubMed ID: 15655783
[TBL] [Abstract][Full Text] [Related]
39. Enterococcal bacteraemia in a tertiary care hospital of North India.
Mohanty S; Kapil A; Das BK
J Indian Med Assoc; 2005 Jan; 103(1):31-2, 34, 36-7. PubMed ID: 16008327
[TBL] [Abstract][Full Text] [Related]
40. E. faecalis vancomycin-sensitive enterococcal bacteremia unresponsive to a vancomycin tolerant strain successfully treated with high-dose daptomycin.
Cunha BA; Mickail N; Eisenstein L
Heart Lung; 2007; 36(6):456-61. PubMed ID: 18005808
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
